Lilly reports Phase 3b EBGLYSS data
Lilly said new Phase 3b data for EBGLYSS showed significant and rapid improvements in skin clearance, itch, pain and patient satisfaction in moderate-to-severe hand and foot atopic dermatitis.
Lilly said new Phase 3b data for EBGLYSS showed significant and rapid improvements in skin clearance, itch, pain and patient satisfaction in moderate-to-severe hand and foot atopic dermatitis.